Instrument NameTeva Pharmaceutical Industries ADRInstrument Symbol(TEVA-N)

Instrument ExchangeNYSE

New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves targeted at specific brain regions and has shown...

TEVA earnings call for the period ending June 30, 2024.

This week we have Apple, Advanced Micro Devices, Amazon, Pfizer, Coinbase, Meta Platforms, Intel, Exxon Mobil, Boeing, PayPal, Starbucks, McDonald’s and Chevron all set to report.

A modest amount of money can go a long way on Wall Street when it's put to work in innovation-driven businesses.

TEVA earnings call for the period ending March 31, 2024.

Teva Pharmaceuticals, the generic drug maker, posted good Q1 results today, reaffirming its forecast for significant free cash flow in 2024. That led to unusual call options activity based on a Barchart report.

Three highly successful billionaire money managers are paring down their respective stakes in artificial intelligence (AI) titan Nvidia and purchasing shares of six beaten-down value stocks.

A relatively modest amount of money can go a long way when it's put to work in top-tier businesses with abundant catalysts.

TEVA earnings call for the period ending December 31, 2023.

This mix of growth and value stocks appears set to outperform -- and hopefully makes me a lot richer in the process.

As the third quarter 2023 earnings season ends, it's worth looking back to see which stocks may have been overlooked or mispriced on their results

TEVA earnings call for the period ending September 30, 2023.

You don't need a boatload of cash to begin growing your wealth on Wall Street.